HNF4A heterozygous mutations affect both liver and pancreas development. MODY1 patients present neonatal hyperinsulinemia and impairment in β cell function. They present normal insulin sensitivity but decreased insulin secretion. Here, INS is linked to Hyperinsulinemia.